Amalgamated Bank’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.75M | Sell |
10,855
-159
| -1% | -$73.4K | 0.04% | 384 |
|
|
2026
Q1 | $5.29M | Buy |
11,014
+236
| +2% | +$121K | 0.04% | 399 |
|
|
2025
Q4 | $6.05M | Sell |
10,778
-51
| -0.5% | -$28.9K | 0.04% | 340 |
|
|
2025
Q3 | $5.57M | Sell |
10,829
-437
| -4% | -$191K | 0.04% | 369 |
|
|
2025
Q2 | $3.54M | Sell |
11,266
-612
| -5% | -$184K | 0.03% | 542 |
|
|
2025
Q1 | $3.62M | Sell |
11,878
-599
| -5% | -$201K | 0.03% | 509 |
|
|
2024
Q4 | $4.14M | Sell |
12,477
-207
| -2% | -$70.2K | 0.03% | 468 |
|
|
2024
Q3 | $4.23M | Buy |
12,684
+373
| +3% | +$142K | 0.03% | 459 |
|
|
2024
Q2 | $5.07M | Sell |
12,311
-653
| -5% | -$259K | 0.04% | 406 |
|
|
2024
Q1 | $5.24M | Sell |
12,964
-3,686
| -22% | -$1.3M | 0.04% | 436 |
|
|
2023
Q4 | $5.1M | Sell |
16,650
-251
| -1% | -$67.8K | 0.04% | 463 |
|
|
2023
Q3 | $4.09M | Sell |
16,901
-684
| -4% | -$175K | 0.03% | 539 |
|
|
2023
Q2 | $4.22M | Buy |
17,585
+641
| +4% | +$133K | 0.03% | 528 |
|
|
2023
Q1 | $3.19M | Sell |
16,944
-960
| -5% | -$199K | 0.03% | 665 |
|
|
2022
Q4 | $3.8M | Buy |
17,904
+314
| +2% | +$62.7K | 0.03% | 621 |
|
|
2022
Q3 | $2.77M | Sell |
17,590
-794
| -4% | -$127K | 0.03% | 685 |
|
|
2022
Q2 | $2.75M | Sell |
18,384
-1,197
| -6% | -$173K | 0.03% | 740 |
|
|
2022
Q1 | $3.2M | Sell |
19,581
-933
| -5% | -$154K | 0.02% | 724 |
|
|
2021
Q4 | $4.46M | Buy |
20,514
+127
| +0.6% | +$26.6K | 0.03% | 575 |
|
|
2021
Q3 | $3.86M | Sell |
20,387
-1,594
| -7% | -$291K | 0.03% | 640 |
|
|
2021
Q2 | $3.88M | Buy |
21,981
+17,811
| +427% | +$3.07M | 0.03% | 672 |
|
|
2021
Q1 | $684K | Sell |
4,170
-384
| -8% | -$58.7K | 0.03% | 800 |
|
|
2020
Q4 | $634K | Buy |
4,554
+88
| +2% | +$11.1K | 0.02% | 830 |
|
|
2020
Q3 | $499K | Sell |
4,466
-142
| -3% | -$16.4K | 0.02% | 835 |
|
|
2020
Q2 | $429K | Sell |
4,608
-493
| -10% | -$42K | 0.02% | 917 |
|
|
2020
Q1 | $374K | Sell |
5,101
-84
| -2% | -$7.29K | 0.01% | 1043 |
|
|
2019
Q4 | $436K | Buy |
5,185
+108
| +2% | +$8.36K | 0.01% | 1198 |
|
|
2019
Q3 | $427K | Sell |
5,077
-88
| -2% | -$6.65K | 0.01% | 1121 |
|
|
2019
Q2 | $338K | Buy |
5,165
+1,544
| +43% | +$89K | 0.01% | 1284 |
|
|
2019
Q1 | $214K | Buy |
+3,621
| New | +$216K | 0.01% | 1475 |
|
Other funds holding MEDP
WA
Amalgamated Bank's MEDP Position: Q2 2026 in Review
Amalgamated Bank reduced its Medpace (MEDP) stake by 1.4% in Q2 2026, selling an estimated $73.4K and leaving 10,855 shares worth $5.75M. The position accounts for 0.04% of the portfolio, ranked #384.
Amalgamated Bank first reported a position in MEDP in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.05M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Amalgamated Bank held 10,855 shares of Medpace worth $5.75M as of Q2 2026.
- Amalgamated Bank sold 159 Medpace shares in Q2 2026, an estimated $73.4K.
- Medpace made up 0.04% of Amalgamated Bank's portfolio in Q2 2026, its #384 holding.
- Amalgamated Bank first reported a position in Medpace in Q1 2019 and has held it in 30 quarters since.
- Amalgamated Bank's Medpace position peaked at $6.05M in Q4 2025.
- 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.